Developing novel biotherapeutics involves complex bioanalytical challenges, including the need for high-quality critical reagents and robust assay validation. Inefficient reagent management and inconsistent analytical methods can lead to delays, increased costs, and potential regulatory hurdles in the drug development lifecycle.

B2S Life Sciences provides comprehensive bioanalytical services and custom critical reagent solutions to support biopharmaceutical R&D. They offer expertise in assay development, validation, and sample analysis, coupled with proprietary life cycle management for reagents to ensure consistency and regulatory compliance. Their integrated approach aims to streamline the analytical workflow, from early-stage research through to late-stage development and regulatory submissions. By providing tailored solutions and expert consulting, B2S Life Sciences helps clients accelerate their biotherapeutic development programs and achieve successful outcomes.

Custom critical reagent development, manufacturing, and characterization for assay optimization.

Proprietary Life Cycle Management (LCM+) system for controlled inventory and long-term stability of reagents.

Bioanalytical method development and validation for ligand binding assays, immunogenicity, and pharmacokinetics (PK).

GLP-compliant bioanalysis for nonclinical and clinical sample testing.

Data analytics and statistical support for immunoassay validation, clinical immunogenicity reports, and PK/PD analysis.

Biotherapeutic CMC support, including formulation and regulatory compliance.

Consulting services for bioanalytical project management and regulatory sciences.

Development of novel affinity purification techniques for custom antibody production.

The primary clients are pharmaceutical and biotechnology companies, as well as contract research organizations (CROs), engaged in the development of biotherapeutic drugs and diagnostics.